Curis Inc Positive Emavusertib Update Transcript
Good morning, and welcome to Curis' Emavusertib Update Call. (Operator Instructions) Please note this event is being recorded. And I would now like to turn the conference over to Diantha Duvall, Curis' Chief Financial Officer. Diantha, please go ahead.
Thank you, and welcome to Curis' Emavusertib update call. Before we begin, I would like to encourage everyone to go to the Investors section of our website at www.curis.com to find the Curis announces positive emavusertib update press release. I would also like to remind everyone that during our call, we will be making forward-looking statements, which are based on our current expectations and beliefs.
These statements are subject to certain risks and uncertainties, and actual results may differ materially. For additional details, please see our SEC filings. Joining me on today's call are Jim Dentzer, President and Chief Executive Officer; Dr. Ahmed Hamdy, Chief Medical Officer; and Dr.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
